BP002450-CA25: Recombinant Human Interleukin-28B (IL-28B) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000152-CYT-117: Recombinant Human IL-29, HEK
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.5-5 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.BP000152-CYT-603: Recombinant Human IL-29
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE and RP-HPLC.BP002450-CYT-105: Recombinant Human Interleukin-28B (IL-28B) Protein
Source: HEK-derived.
The specific activity was determined by the dose dependent protection of the cytopathic effect on A549 cells (human lung adenocarcinoma epithelial cell line) that were challenged with encephalomyocarditis (EMC) virus and is typically 0.1-1 ng/ml.
Purity: > 95% as obsereved by SDS-PAGE.